PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product

Ads

You May Also Like

Resverlogix Announces Participation in Upcoming Conferences

CALGARY, Alberta, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") ...

PositiveID Adds Benedikt von Braunmuhl to its Board of Advisors

DELRAY BEACH, Fla., May 31, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) ...

Rexahn Pharmaceuticals Receives New U.S. Patent for Supinoxin™

ROCKVILLE, Md., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...